0001740695 false 04/30 2022 Q2 0001740695 2021-05-01 2021-10-31 0001740695 2021-12-14 0001740695 2021-10-31 0001740695 2021-04-30 0001740695 2021-08-01 2021-10-31 0001740695 2020-08-01 2020-10-31 0001740695 2020-05-01 2020-10-31 0001740695 us-gaap:CommonStockMember 2021-07-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001740695 us-gaap:RetainedEarningsMember 2021-07-31 0001740695 us-gaap:NoncontrollingInterestMember 2021-07-31 0001740695 2021-07-31 0001740695 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001740695 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001740695 us-gaap:NoncontrollingInterestMember 2021-08-01 2021-10-31 0001740695 us-gaap:CommonStockMember 2021-10-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001740695 us-gaap:RetainedEarningsMember 2021-10-31 0001740695 us-gaap:NoncontrollingInterestMember 2021-10-31 0001740695 us-gaap:CommonStockMember 2020-07-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001740695 us-gaap:RetainedEarningsMember 2020-07-31 0001740695 us-gaap:NoncontrollingInterestMember 2020-07-31 0001740695 2020-07-31 0001740695 us-gaap:CommonStockMember 2020-08-01 2020-10-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2020-08-01 2020-10-31 0001740695 us-gaap:RetainedEarningsMember 2020-08-01 2020-10-31 0001740695 us-gaap:NoncontrollingInterestMember 2020-08-01 2020-10-31 0001740695 us-gaap:CommonStockMember 2020-10-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0001740695 us-gaap:RetainedEarningsMember 2020-10-31 0001740695 us-gaap:NoncontrollingInterestMember 2020-10-31 0001740695 2020-10-31 0001740695 us-gaap:CommonStockMember 2021-04-30 0001740695 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0001740695 us-gaap:RetainedEarningsMember 2021-04-30 0001740695 us-gaap:NoncontrollingInterestMember 2021-04-30 0001740695 us-gaap:CommonStockMember 2021-05-01 2021-10-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2021-10-31 0001740695 us-gaap:RetainedEarningsMember 2021-05-01 2021-10-31 0001740695 us-gaap:NoncontrollingInterestMember 2021-05-01 2021-10-31 0001740695 us-gaap:CommonStockMember 2020-04-30 0001740695 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0001740695 us-gaap:RetainedEarningsMember 2020-04-30 0001740695 us-gaap:NoncontrollingInterestMember 2020-04-30 0001740695 2020-04-30 0001740695 us-gaap:CommonStockMember 2020-05-01 2020-10-31 0001740695 us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2020-10-31 0001740695 us-gaap:RetainedEarningsMember 2020-05-01 2020-10-31 0001740695 us-gaap:NoncontrollingInterestMember 2020-05-01 2020-10-31 0001740695 us-gaap:WarrantMember 2021-05-01 2021-10-31 0001740695 us-gaap:WarrantMember 2020-05-01 2020-10-31 0001740695 us-gaap:StockOptionMember 2021-05-01 2021-10-31 0001740695 us-gaap:StockOptionMember 2020-05-01 2020-10-31 0001740695 LXAM:ConvertibleDebentures1Member 2021-04-30 0001740695 LXAM:ConvertibleDebentures1Member 2020-05-01 2021-04-30 0001740695 LXAM:ConvertibleDebentures2Member 2021-04-30 0001740695 LXAM:ConvertibleDebentures2Member 2020-05-01 2021-04-30 0001740695 LXAM:VehicleNotePayableMember 2021-10-31 0001740695 LXAM:VehicleNotePayableMember 2021-04-30 0001740695 LXAM:PaycheckProtectionProgramMember LXAM:SBAMember 2020-05-01 2020-05-08 0001740695 LXAM:PaycheckProtectionProgramMember LXAM:SBAMember 2020-05-08 0001740695 LXAM:PaycheckProtectionProgramMember 2020-11-01 2020-11-30 0001740695 LXAM:PromissoryNoteMember us-gaap:InvestorMember 2021-01-01 2021-02-02 0001740695 LXAM:PromissoryNoteMember us-gaap:InvestorMember 2021-02-02 0001740695 LXAM:PromissoryNoteMember us-gaap:InvestorMember 2020-05-01 2021-04-30 0001740695 LXAM:PromissoryNoteMember us-gaap:InvestorMember 2021-05-01 2021-10-31 0001740695 LXAM:PaycheckProtectionProgramMember 2021-02-01 2021-02-11 0001740695 LXAM:PaycheckProtectionProgramMember 2021-02-11 0001740695 LXAM:PaycheckProtectionProgramMember 2021-02-01 2021-02-14 0001740695 LXAM:PaycheckProtectionProgramMember 2021-02-14 0001740695 LXAM:PaycheckProtectionProgramMember 2021-03-01 2021-03-16 0001740695 LXAM:PaycheckProtectionProgramMember 2021-03-16 0001740695 LXAM:PaycheckProtectionProgramMember 2021-04-01 2021-04-19 0001740695 LXAM:PaycheckProtectionProgramMember 2021-04-19 0001740695 LXAM:PaycheckProtectionProgramMember 2021-05-01 2021-05-10 0001740695 LXAM:PaycheckProtectionProgramMember 2021-05-10 0001740695 LXAM:PaycheckProtectionProgramMember 2021-05-01 2021-05-19 0001740695 LXAM:PaycheckProtectionProgramMember 2021-05-19 0001740695 LXAM:PaycheckProtectionProgramMember 2021-06-01 2021-06-07 0001740695 LXAM:PaycheckProtectionProgramMember 2021-06-07 0001740695 LXAM:PaycheckProtectionProgram1Member 2021-06-01 2021-06-07 0001740695 LXAM:PaycheckProtectionProgram1Member 2021-06-07 0001740695 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember LXAM:ThreeCustomerMember 2021-05-01 2021-10-31 0001740695 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember LXAM:FourCustomerMember 2020-05-01 2020-10-31 0001740695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember LXAM:TwoCustomerMember 2021-05-01 2021-10-31 0001740695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember LXAM:TwoCustomerMember 2020-05-01 2020-10-31 0001740695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember LXAM:ThreeCustomerMember 2021-08-01 2021-10-31 0001740695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember LXAM:TwoCustomerMember 2020-08-01 2020-10-31 0001740695 2021-05-01 2021-07-31 0001740695 LXAM:ConsultantMember 2017-01-01 2017-03-31 0001740695 LXAM:ConsultantMember 2017-03-31 0001740695 LXAM:ConsultantMember 2020-04-30 0001740695 2019-04-30 0001740695 2019-05-01 2020-04-30 0001740695 2020-05-01 2021-04-30 0001740695 LXAM:StockPlan2016Member 2017-02-02 0001740695 us-gaap:StockOptionMember 2021-04-30 0001740695 us-gaap:StockOptionMember 2020-05-01 2021-04-30 0001740695 us-gaap:StockOptionMember 2021-05-01 2021-10-31 0001740695 us-gaap:StockOptionMember 2021-10-31 0001740695 us-gaap:StockOptionMember 2020-04-30 0001740695 us-gaap:StockOptionMember 2019-05-01 2020-04-30 0001740695 us-gaap:StockOptionMember 2020-05-01 2020-10-31 0001740695 us-gaap:StockOptionMember 2020-10-31 0001740695 LXAM:FourShareholdersMember 2021-05-01 2021-10-31 0001740695 LXAM:FourShareholdersMember 2020-05-01 2020-10-31 0001740695 LXAM:FourShareholdersMember 2021-08-01 2021-10-31 0001740695 LXAM:FourShareholdersMember 2020-08-01 2020-10-31 0001740695 LXAM:FourShareholdersMember 2021-07-31 0001740695 LXAM:FourShareholdersMember 2021-04-30 0001740695 LXAM:VehicleRental1Member 2021-05-01 2021-10-31 0001740695 LXAM:VehicleRental2Member 2021-05-01 2021-10-31 0001740695 LXAM:VehicleRental1Member 2021-08-01 2021-10-31 0001740695 LXAM:VehicleRental2Member 2021-08-01 2021-10-31 0001740695 LXAM:VehicleRental1Member 2020-05-01 2020-10-31 0001740695 LXAM:VehicleRental2Member 2020-05-01 2020-10-31 0001740695 LXAM:VehicleRental1Member 2020-08-01 2020-10-31 0001740695 LXAM:VehicleRental2Member 2020-08-01 2020-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: October 31, 2021

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from__________ to __________

 

COMMISSION FILE NUMBER: 000-56207

 

Lux Amber, Corp.

(Exact name of registrant as specified in its charter)

 

Nevada 000-55554 98-1414834
(State or other jurisdiction
of incorporation or organization)
(Commission
File No.)
(IRS Employee
Identification No.)

 

6136 Frisco Square Blvd.

Suite 400, #237

Frisco, TX 75034

(Address of Principal Executive Offices)

 

972-214-9764

(Issuer Telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol(s) Name of each exchange on which registered
Common Stock LXAM N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒        No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes ☐       No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated Filer ☐
Non-accelerated filer Smaller reporting company
Emerging Growth Company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).            Yes  ☐        No  ☒

 

The number of Registrant’s shares of common stock, $0.0001 par value, outstanding as of December 14, 2021, was 31,111,658.

 

 

   

 

 

TABLE OF CONTENTS

 

    Page
     
PART I.  FINANCIAL INFORMATION 4
     
  Item 1 Condensed Consolidated Financial Statements 4
       
  Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 20
       
  Item 4 Controls and Procedures 22
       
PART II.  OTHER INFORMATION 23
     
  Item 1 Legal Proceedings 23
       
  Item 1A Risk Factors 23
       
  Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 23
       
  Item 3 Defaults Upon Senior Securities 23
       
  Item 4 Mine Safety Disclosures 23
       
  Item 5 Other Information 23
       
  Item 6 Exhibits 23
       
SIGNATURES 24

 

 

 

 3 

 

 

PART 1 - FINANCIAL INFORMATION

 

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

 

LUX AMBER, CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

     

           
   October 31, 2021   April 30, 2021 
   (Unaudited)   (Audited) 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents  $   $ 
Accounts receivable   178,556    112,982 
Inventory   85,528    137,211 
Prepaid expenses   2,000    2,000 
Other current assets   11,517    5,960 
Total current assets   277,601    258,153 
           
GOODWILL   2,294,953    2,294,953 
           
OTHER INTANGIBLES   15,000    15,000 
           
OTHER LONG-TERM ASSETS   26,965     
           
FIXED ASSETS          
Furniture, fixtures, and office equipment   41,787    36,256 
Vehicles and trailers   284,650    284,650 
Equipment   649,910    649,910 
Leasehold improvements   12,190    12,190 
Assets in process   27,301    14,259 
TOTAL FIXED ASSETS   1,015,838    997,265 
Accumulated depreciation   (564,702)   (484,568)
Fixed assets, net   451,136    512,697 
           
RIGHT OF USE ASSETS   341,659    272,657 
           
TOTAL ASSETS  $3,407,314   $3,353,460 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
           
CURRENT LIABILITIES          
Accounts payable  $756,026   $554,588 
Accrued expenses   1,332,649    1,201,568 
Related party payables   66,522    208,756 
Notes payable – current portion   128,664    112,889 
Right of use liabilities – current portion   172,498    172,498 
Total current liabilities   2,456,359    2,250,299 
           
NON-CURRENT LIABILITIES          
Notes payable   111,963    14,735 
Right of use liabilities   147,209    98,761 
Paycheck Protection Program loans   104,752    104,752 
TOTAL LIABILITIES   2,820,283    2,468,547 
           
           
STOCKHOLDERS’ EQUITY          
           
Common stock, $0.0001 par value, 75,000,000 shares authorized: 31,111,658 issued and outstanding shares as of October 31, 2021, and 31,111,658 issued and outstanding shares as of April 30, 2021   3,273    3,107 
Additional paid-in capital   16,181,303    15,750,430 
Accumulated deficit   (15,597,545)   (14,868,624)
TOTAL EQUITY   587,031    884,913 
           
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $3,407,314   $3,353,460 

 

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

 

 4 

 

 

LUX AMBER, CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

     

 

                     
  

Three months

ended

October 31, 2021

  

Three months

ended

October 31, 2020

  

Six months

ended

October 31, 2021

  

Six months

ended

October 31, 2020

 
                 
Revenue  $433,920   $396,155   $857,748   $686,415 
Cost of goods sold   295,699    211,555    482,013    425,454 
Gross Profit   138,221    184,600    375,735    260,961 
                     
Product delivery expenses   119,424    159,285    272,639    301,266 
General and administrative expenses   383,144    555,979    719,302    1,027,757 
Selling expenses   3,440    18,513    10,542    35,755 
Depreciation and amortization   38,351    37,683    79,971    74,967 
                     
Total operating expenses   544,359    771,460    1,082,454    1,439,745 
                     
Loss from operations   (406,138)   (586,860)   (706,719)   (1,178,784)
                     
Other (income)/expenses                    
Interest expense   8,242    19,987    17,082    23,295 
Other (income)/expense       31,343    5,120    (3,280)
Total other expense   8,242    51,330    22,202    20,015 
                     
Net loss  $(414,380)  $(638,190)  $(728,921)  $(1,198,799)
                     
Loss per common share:                    
Basic and diluted  $(0.01)  $(0.02)  $(0.02)  $(0.04)
                     
Weighted Average Number of Common Shares Outstanding:                    
Basic and diluted   32,511,658    30,606,332    32,511,658    30,262,690 

 

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

 

 

 

 5 

 

 

LUX AMBER, CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

For the Three Months Ended October 31, 2021 and October 31, 2020

 

 

                                               
    Number of Shares     Common Stock Par     Additional Paid-in     Accumulated     Non-Controlling     Total  
    Issued and     Value Amount     Capital     Deficit     Interest        
    Outstanding                                
Balance as of July 31, 2021     31,111,658     $ 3,237     $ 16,016,786     $ (15,183,165 )         $ 836,858  
Common stock sold           30       99,970                   100,000  
Common stock issued for outstanding payables         6       19,994                   20,000  
Stock based compensation                 44,553                   44,553  
Net loss                       (414,380 )           (414,380 )
Balance as of October 31, 2021     31,111,658     $ 3,273     $ 16,181,303     $ (15,597,545 )         $ 587,031  

 

 

    Number of Shares     Common Stock Par     Additional Paid-in     Accumulated     Non-Controlling     Total  
    Issued and     Value Amount     Capital     Deficit     Interest        
    Outstanding                                          
Balance as of July 31, 2020     30,293,316     $ 3,027     $ 14,857,575     $ (13,443,918 )         $ 1,416,684  
Adjustments     (267 )           15,187                   15,087  
Notes payable with interest converted   651,693       46       560,399                   560,455  
Share based compensation                 44,553                   44,553  
Net loss                       (638,190 )           (638,190 )
Balance as of October 31, 2020   30,944,742     $ 3,073     $ 15,477,714     $ (14,082,108 )         $ 1,398,679  

 

 6 

 

 

LUX AMBER, CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

For the Six Months Ended October 31, 2021 and October 31, 2020

 

    Number of Shares     Common Stock Par     Additional Paid-in     Accumulated     Non-Controlling     Total  
    Issued and     Value Amount     Capital     Deficit     Interest        
    Outstanding                                          
Balance as of April 30, 2021     31,111,658     $ 3,107     $ 15,750,430     $ (14,868,624 )         $ 884,913  
Options exercised (cashless)           60       (60 )                    
Options exercised           40       3,960                     4,000  
Common stock sold           30       149,970                     150,000  
Common stock sold             30       99,970                       100,000  
Common stock issued for outstanding payables           6       19,994                       20,000  
Stock based compensation                 157,039                   157,039  
Net loss                       (728,921 )             (728,921 )
Balance as of October 31, 2021     31,111,658     $ 3,273     $ 16,181,303     $ (15,597,545 )         $ 587,031  

 

   Number of Shares
Issued and
Outstanding
   Common Stock Par
Value Amount
   Additional Paid-in
Capital
   Accumulated
Deficit
   Non-Controlling Interest   Total 
Balance as of April 30, 2020   29,441,708   $2,943   $14,095,093   $(12,884,427)  $1,027   $1,214,636 
Common stock repurchased   (36,250)   (5)   (45,308)           (45,313)
Notes payable with interest converted   1,539,551    135    1,323,636            1,323,771 
Dissolution of PCNM               1,118    (1,027)   91 
Adjustments   (267)       15,187            15,187 
Share based compensation           89,106            89,106 
Net loss               (1,198,799)       (1,198,799)
Balance as of October 31, 2020   30,944,742   $3,073   $15,477,714   $(14,082,108)  $   $1,398,679 

 

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

 

 

 7 

 

 

LUX AMBER, CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

           
   For the
Six Months Ended
October 31, 2021
   For the
Six Months Ended
October 31, 2020
 
Cash Flows from Operating Activities          
Net loss  $(728,921)  $(1,198,799)
Adjustments to reconcile net loss to net cash used in operating activities          
Depreciation and amortization   175,694    160,865 
Share based compensation   157,039    89,106 
Right of use interest   2,426    8,066 
Change in current assets and current liabilities          
Accounts receivable - trade   (65,574)   (33,977)
Inventory   51,683    (30,989)
Prepaid expenses and other current assets   (32,522)   (30,571)
Accounts payable and accrued expenses   279,838    658,990 
Due to related parties   (142,234)   (17,794)
Net cash used in operating activities   (302,571)   (395,103)
           
Cash Flows from Investing Activities          
Deposit paid       (5,000)
Expenditures for property and equipment   (18,410)   (91,538)
Net cash used in investing activities   (18,410)   (96,538)
           
Cash Flows from Financing Activities          
Proceeds from convertible notes payable and interest payable       571,300 
Payments on notes payable       (2,910)
Payments on right of use liabilities   (46,022)   (80,621)
Payments for the repurchase of common stock       (45,313)
Payments on promissory notes   (13,997)    
Proceeds from promissory notes   127,000     
Proceeds from stock sales   250,000     
Proceeds from exercise of options   4,000     
Net cash provided by financing activities   320,981    442,456 
           
Net change in cash and cash equivalents       (49,185)
           
Cash at beginning of period       49,185 
           
Cash at end of period  $   $ 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION          
Cash paid during period for:          
Interest  $7,527   $19,735 
Noncash Financing Activities  $20,000   $ 
Convertible notes and accrued interest converted to common stock  $   $1,323,781 
Common stock issued for reduction of outstanding payments  $20,000   $ 
Common stock sold for note receivable  $50,000   $ 
Right of use asset and lease liability additions  $137,347   $ 

 

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

 

 

 8 

 

 

LUX AMBER, CORP. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

 

October 31, 2021

(Unaudited)

 

 

NATURE OF BUSINESS

 

Lux Amber, Corp. (“LAC”), formed on January 19, 2018, is an international specialty chemical company. Its corporate offices are currently located at 6136 Frisco Square Blvd., Suite 400, #237, Frisco, TX 75034. LAC’s corporate telephone number is 972-214-9764. LAC has a stock symbol of LXAM.

 

LAC has three (3) wholly owned subsidiaries (collectively with LAC, the “Company”): Worldwide Specialty Chemicals, Inc. (“WSCI”), Industrial Chem Solutions, Inc. (“ICS”), and Safeway Pest Elimination, LLC, (“SPE”), which was formed July 16, 2018. LAC and its subsidiaries serve as both producers and distributors of environmentally safe, specialty chemicals. The Company formerly held a 49% interest in PCNM LLC, a Service-Disabled Veteran owned small business that sold the Company’s products to government agencies. PCNM was legally dissolved on July 31, 2020.

 

The Company’s products utilize all-natural and renewable resources, contain no dangerous chemicals or additives, and offer “green” solutions to its customers. ICS’ product line includes asphalt release agents, industrial cleaners, environmental remediation gels, odor control agents, and consumer friendly cleaners for a wide range of uses, including construction, environmental remediation, hazardous materials clean-up, nuclear decommissioning, industrial cleaning, and odor control. SPE’s products are designed for the elimination and control of pests.

 

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A summary of the significant accounting polices consistently applied in the preparation of the accompanying consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP) is as follows.

 

Basis of Consolidation

 

The consolidated financial statements include the accounts of LAC, WSCI, ICS, SPE, and PCNM. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Fair Value of Financial Instruments

 

FASB ASC 825-10 requires disclosure of fair value information about certain financial instruments, including, but not limited to, cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, related party payables, notes payable, and Paycheck Protection Program loans. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management on October 31, 2021 and April 30, 2021. The carrying value of the financial instruments included in the Company’s consolidated financial statements approximated their fair values.

 

 

 

 9 

 

 

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities are carried at, or approximate, fair value as of the reporting date because of their short-term nature.

 

The carrying value of the notes payable approximates fair value as they bear market rates of interest.

 

Basic and Diluted Net Loss Per Share

 

Basic net loss per share is computed using the weighted average number of common shares outstanding. Diluted loss per share has not been presented because there are no dilutive items. Diluted earnings loss per share is based on the assumption that all dilutive stock options, warrants, and convertible debt are converted or exercised by applying the treasury stock method. Under this method, options and warrants are assumed exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Options, warrants and/or convertible debt will have a dilutive effect, during periods of net profit, only when the average market price of the common stock during the period exceeds the exercise or conversion price of the items.

 

For the six months ended October 31, 2021 and 2020, approximately 82,668 and 82,668 common stock warrants, respectively, and 6,749,750 and 6,469,750 common stock options, respectively, were not added to the diluted average shares because inclusion of such warrants and options would be antidilutive.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an initial maturity of three months or less, when purchased, to be cash equivalents. The Company maintains cash balances at several financial institutions located throughout the United States, which at times may exceed insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivables are recorded at invoiced amount and generally do not bear interest. An allowance for doubtful accounts is established, as necessary, based on experience and other factors which, in management's judgment, deserve current recognition in estimating bad debts. Such factors include growth and composition of accounts receivable, the relationship of the allowance for doubtful accounts to accounts receivable, and current economic conditions. The determination of the collectability of amounts due requires the Company to make judgments regarding future events and trends. Allowances for doubtful accounts are determined based on assessing the Company’s portfolio on an individual customer and on an overall basis. This process consists of a review of historical collection experience, current aging status of the customer account, and the financial condition of the Company’s customers. Based on a review of these factors, the Company establishes or adjusts the allowance for specific customers and the accounts receivable portfolio as a whole. On October 31, 2021 and April 30, 2021, the allowance for doubtful accounts was $0.

 

Revenue Recognition

  

Revenue is measured as the amount of consideration expected to be received in exchange for transferring goods or providing service. Revenue from product sold is recognized when obligations with the customer are satisfied, which generally occurs with the transfer or delivery of the product, signifying the point in time when the customer obtains control of the promised goods. Our performance obligation is delivering the product to the customer; and therefore, the transaction price, which is stated on the invoice, is allocated 100% to the sole performance obligation of product delivery. For the three-month and six-month periods ended October 31, 2021 and 2020, all revenue was from products sold.

 

Our sales policies do not provide for general rights of return, and payment is due net of 15 days. We do not record estimated reductions to revenue for customer programs and incentive offerings including pricing arrangements, promotions, and other volume-based incentives at the time of the sale. We also do not record estimated reserves for product returns and credits at the time of sale and anticipated uncollectible accounts.

  

 

 

 10 

 

 

Sales Taxes

 

Sales (and similar) taxes that are imposed on the Company's sales and collected from customers are excluded from revenues.

 

Shipping and Handling Costs

 

Costs for shipping and handling activities, including those activities that occur after transfer of control to the customer, are recorded as cost of sales and are expensed as incurred. The Company accrues costs for shipping and handling activities that occur after control of the promised good has transferred to the customer.

 

Inventory

 

Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in first-out basis. The carrying value of inventory is reduced for estimated obsolescence. The Company evaluates the inventory carrying value for potential excess and obsolete inventory exposures by analyzing historical and anticipated demand.

 

The following table sets forth the components of the Company’s inventory balances as of:: 

Schedule of inventory          
   October 31,
2021
   April 30,
2021
 
Finished goods  $17,290   $93,203 
Raw materials   85,528    61,298 
Obsolescence   (17,290)   (17,290)
Inventory, net  $85,528   $137,211 

 

Fixed Assets

 

Fixed assets consist of furniture, fixtures and office equipment, vehicles and trailers, equipment and leasehold improvements that are stated at cost, less accumulated depreciation. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to earnings over their estimated service lives (3 – 10 years) under the straight-line method.

 

Maintenance and repairs are charged to earnings as incurred; major repairs and replacements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in operations.

   

Goodwill

 

Goodwill represents the difference between the enterprise value/cash paid less the fair value of all recognized net asset fair values including identifiable intangible asset values in a business combination. The Company reviews goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. The Company considered the current and expected future economic and market conditions surrounding COVID-19 and its impact on the reporting unit. As a result of the certain business developments and changes in the Company's long-term projections, during the fourth quarter of fiscal 2021, the Company concluded a triggering event had occurred that required an impairment assessment to be performed. The qualitative assessment thresholds were not met. The Company calculated the quantitative impairment test of using the implied fair market value using market data and concluded there was no goodwill impairment loss. Based on annual testing, the Company determined that there was no goodwill impairment in Fiscal 2021. The Company noted no triggering events as of October 31, 2021.

 

 

 

 11 

 

 

The Company first evaluates qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of the reporting unit is less than its carrying amount, including goodwill. If after qualitatively assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, then further testing is unnecessary. If after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the Company then estimates the fair value of the reporting unit and compares the fair value of the reporting unit with its carrying amount, including goodwill, as discussed below.

 

The quantitative goodwill impairment test involves a two-step process. In the first step, the Company compares the fair value of each reporting unit to its carrying value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and no further testing is required. If the fair value of the reporting unit is less than the carrying value, the Company must perform the second step of the impairment test to measure the amount of impairment loss. In the second step, the reporting unit's fair value is allocated to all of the assets and liabilities of the reporting unit, including any unrecognized intangible assets, in a hypothetical analysis that calculates the implied fair value of goodwill in the same manner as if the reporting unit was being acquired in a business combination. If the implied fair value of the reporting unit's goodwill is less than the carrying value, the difference is recorded as an impairment loss.

 

Share-Based Compensation

 

The Company recognizes compensation expense for all share-based payments in accordance with FASB Codification Topic 718, Compensation — Stock Compensation, (ASC 718). Under the fair value recognition provisions of ASC 718, the Company recognizes share-based compensation expense, net of an estimated forfeiture rate, over the requisite service period of the award. The fair value at the measurement date of stock options is estimated using the Black-Scholes option-pricing model. Compensation expense is recognized on a straight-line basis over the vesting period based on the estimated number of stock options that are expected to vest.

 

Income Taxes

 

The Company accounts for Federal and state income taxes using the asset and liability approach for financial accounting and reporting for income taxes based on tax effects of differences between the financial statement and tax basis of assets and liabilities.

 

The Company accounts for all uncertain tax positions in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 740 – Income Taxes (“ASC 740”). ASC 740 provides guidance on de-recognition, classification, interest and penalties and disclosure related to uncertain income tax positions. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. There were no accrued interest or penalties as of October 31, 2021 or April 30, 2021.

 

From time to time, the Company may be audited by taxing authorities. These audits could result in proposed assessments of additional taxes. The Company believes that its tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from those of the Company, which could result in the imposition of additional taxes. The Company’s federal returns since 2016 are still subject to examination by taxing authorities.

  

License Fee

 

ICS pays 10% of the net selling price of $9.50 a gallon to CBI Polymers, Inc (“CBI”), as a mutually acceptable license fee. E. Thomas Layton, Chairman and CEO of LAC, is also the Chairman and CEO and controlling shareholder of CBI. During the six-month ended October 31, 2021 and 2020, the Company incurred $7,046 and $5,190 of license fees to CBI for those sales. During the three-month ended October 31,2021, the Company incurred $4,944 and $4,790 of license fees to CBI for those sales.

 

 

 

 12 

 

 

Advertising Costs

 

The Company recognizes expenses for advertising costs as they are incurred. During the six-month ended October 31, 2021 and 2020, the Company incurred $1,569 and $4,790 in advertising costs. During the three-month period ended October 31, 2021 and 2020, the Company incurred $443 and $443 in advertising costs.

   

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred substantial operating losses, resulting in an accumulated deficit of $15,597,545 on October 31, 2021. The Company has a working capital deficit of $2,178,758 as of October 31, 2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are being issued. Accordingly, the Company is arranging for additional financing to fully implement its business plan, including continued growth and establishment of a stronger brand.

 

The Company is actively seeking growth of its service offerings, both organically and via new client relationships. In the ordinary course of the Company’s business, management is trying to raise additional capital through sales of common stock as well as seeking debt financing from third parties. There are current indications that additional financing will be available on favorable terms. If additional financing is not available, the Company will need to reduce salaries, defer, or cancel development programs, planned initiatives and overhead expenditures. The failure to adequately fund its capital requirements could have a material adverse effect on the Company’s business, financial condition, and results of operations, including potential discontinuance of operations. Moreover, the sale of additional equity securities to raise financing will result in additional dilution to the Company’s stockholders. Additionally, incurring additional indebtedness could involve an increased debt service cash obligation, as well as the imposition of covenants that restrict the Company’s operations or the Company’s ability to perform on its current debt service requirements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. While the Company recognizes the significant impact of additional financing, the Company is a smaller reporting company serving large and growing markets and it will continue to sell securities and enter into financing programs which are deemed to be prudent.

 

Recently Issued Accounting Pronouncements

 

Pronouncements Not Yet Adopted

 

In June 2016, the FASB issued ASU 2016-13 Financial Instruments-Credit Losses, which amends how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income, which applies to trade accounts receivable and the calculation of the allowance for uncollectible accounts receivable. The new standard became effective for the Company for annual and interim periods beginning after December 15, 2021, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this accounting guidance will have on the consolidated financial statements.

 

2. ACCOUNTS RECEIVABLE

 

Accounts receivable relate to trade receivables from product sales made by the Company. Accounts receivable consist of the following at October 31, 2021 and April 30, 2021: 

Schedule of accounts receivable          
   October 31,
2021
   April 30,
2021
 
Trade receivables  $178,556   $112,982 

 

 

 

 13 

 

 

3. NOTES PAYABLE

 

Convertible Promissory Notes Payable

During the year ended April 30, 2021, the Company issued a fourth round of convertible debentures in the principal amount of $525,500. The debentures were convertible into shares of the Company’s common stock at the maturity date of September 15, 2020 and pay any unpaid interest at a rate of 8%. The debentures were converted into 611,047 shares of common stock at a price of $0.86 per share and the accrued interest unpaid amount of $16,459 was converted into 19,138 shares of common stock at a price of $0.86 per share.

 

During the year ended April 30, 2021, the Company issued a fifth round of convertible debentures in the principal amount of $204,800. The debentures were convertible into shares of the Company’s common stock at the maturity date of January 15, 2021 and pay any unpaid interest at a rate of 8%. This round of debentures was converted 163,890 shares of common stock at a price of $1.25 per share and accrued interest of $2,074 was converted into 1,660 shares of common stock at a price of $1.25 per share.

  

Vehicles and Equipment Notes Payable

 

The Company has one note payable relating to the purchase of a Company vehicle as of October 31, 2021. The balance outstanding under the note payable was $22,719 as of October 31, 2021. The note payable bears interest of 5.99% with principal and interest due monthly. The note matures in September 2023. The Company had the same note payable relating to the purchase of a Company vehicle as of April 30, 2021 with a balance outstanding of $40,474.

 

The Company’s future minimum principal payments as of October 31, 2021 are as follows: 

     
      
2022  $8,316 
2023   12,889 
2024   1,514 
Total future minimum payment  $22,719 

  

Other Notes Payable

 

On May 8, 2020, the Company received $100,344 from the Paycheck Protection Program. This PPP loan has a two-year term and bears interest at a rate of 1% per annum and does not require collateral. The loan was fully forgiven in November of 2020 by the SBA and a gain on extinguishment of debt of $100,344 was recorded within other income during the year ended April 30, 2021.

 

On February 01, 2021, the Company received $50,000 from an investor and in turn issued a promissory note with an 8% interest rate, with collateral of 8 drag slat application units, and is to be paid in full by February 28, 2022. During the year ended April 30, 2021, the Company had paid $666 in interest for this note. A payment of $5,225 was made during the period ending October 31, 2021.

 

On February 11, 2021, WSC received $40,625 from the Paycheck Protection Program. The PPP Loan has a five-year term and bears interest at a rate of 1% per annum and does not require collateral. Monthly principal and interest payments are deferred for ten months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. WSC has not yet applied for forgiveness but believes it will be forgiven.

 

On February 14, 2021, ICS received $48,510 from the Paycheck Protection Program. The PPP Loan has a five-year term and bears interest at a rate of 1% per annum and does not require collateral. Monthly principal and interest payments are deferred for ten months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. ICS has not yet applied for forgiveness but believes it will be forgiven.

 

On March 16, 2021, SPE received $15,657 from the Paycheck Protection Program. The PPP Loan has a five-year term and bears interest at a rate of 1% per annum and does not require collateral. Monthly principal and interest payments are deferred for ten months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. SPE has not yet applied for forgiveness but believes it will be forgiven.

 

 

 

 14 

 

 

On April 19, 2021, the Company received $50,000 from an investor and in turn issued a promissory note with an 8% interest rate to reduce debt. This note does not require collateral and is to be paid in full by May 19, 2022. No payments have been made at this time.

 

On May 10, 2021, the Company received $25,000 from an investor and in turn issued a promissory note with an 6% interest rate to reduce debt. This note does not require collateral and is to be paid in full by August 6, 2021. No payments have been made at this time.

 

On May 19, 2021, the Company received $50,000 from an investor and in turn issued a promissory note with an 8% interest rate to reduce debt. This note does not require collateral and is to be paid in full by May 19, 2022. No payments have been made at this time.

 

On June 7, 2021, the Company received $26,000 from an investor and in turn issued a promissory note with an 6% interest rate to reduce debt. This note does not require collateral and is to be paid in full by August 7, 2021. No payments have been made at this time.

 

On June 7, 2021, the Company received $20,000 from another investor and in turn issued a promissory note with an 6% interest rate to reduce debt. This note does not require collateral and is to be paid in full by August 7, 2021. No payments have been made at this time.

 

4. ACCRUED EXPENSES

 

Accrued expenses, consisting of accrued salaries for officers and executive management, include the following balance at October 31, 2021 and April 30, 2021: 

          
   October 31,
2021
   April 30,
2021
 
Accrued Compensation  $1,059,739   $934,104 
Other Accrued Expenses   272,910    267,464 
Accrued expenses  $1,332,649   $1,201,568 

 

5. COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

 

Leases

 

As of October 31, 2021, the weighted average remaining lease term and weighted average discount rate for financing leases was 2.4 years and 3.95%, respectively. The Company's future financing lease obligations that have not yet commenced are immaterial. For six-month period October 31, 2021 and October 31, 2020, the Company's cash paid for financing leases was $46,022 and $80,621, and short-term lease costs were $0 and $0, respectively. For the three-month period October 31, 2021 and 2020, the Company paid $37,343 and $24,345 for financing leases.

 

The Company’s undiscounted annual future minimum lease payments as of October 31, 2021 consist of: 

     
2022  $112,688 
2023   142,902 
2024   65,900 
2025   33,339 
2026   13,994 
Total lease payments   368,822 
Interest   (49,115)
Present value of lease liabilities  $319,707 

 

Concentrations

 

As of October 31, 2021, the Company had three customers which made up 60% of the outstanding accounts receivable balance. For the six months ended October 31, 2020, the Company had four customers which made up 63% of the outstanding accounts receivable balance.

 

For the six months ended October 31, 2021, the Company had two customers which made up 50% of total revenues. For the six months ended October 31, 2020, the Company had two customers which made up 48% of total revenues. For the three months ended October 31, 2021, the Company had three customers which made up 64% of total revenues. For the three months ended October 31, 2020, the Company had two customers which made up 46% of total revenues.

 

 

 

 15 

 

 

6. STOCKHOLDERS’ EQUITY

 

Common Stock

 

As of October 31, 2021 and 2020, the authorized share capital of the Company consisted of 75,000,000 shares of common stock with $0.0001 par value. No other classes of stock are authorized.

 

During the three-month period ended July 31, 2021, the Company sold 400,000 shares at $.50 per share for $150,000 in cash proceeds and $50,000 in an assigned note receivable.

 

During the three-month period ended October 31, 2021, the Company issued 60,000 shares at $0.33 per share for $20,000 in outstanding payables.

 

During the three-month period ended October 31, 2021, the Company sold 300,000 shares at $0.33 per share for $100,000 in cash proceeds.

 

Warrants

  

On March 31, 2017, the Company issued 600,000 warrants at an exercise price of $.50 for services provided to a consultant. The warrants expire on March 31, 2024. The fair value of these warrants upon issuance was $302.

  

As of October 31, 2021, and April 30, 2020, there were 82,668 common stock warrants outstanding, respectively, with an exercise price of $0.50

 

                         
Period  Beg. Balance   Issued   Exercised   Expired   End. Balance 
April 30, 2020   82,668                82,668 
April 30, 2021   82,668                82,668 
July 31, 2021   82,668                82,668 
October 31, 2021   82,668                82,668 

 

Stock option plan

 

Effective February 1, 2017, the Company established the 2016 Stock Option Plan (the “Plan”). The Board of Directors of the Company has the authority and discretion to grant stock options. The maximum number of shares of stock that may be issued pursuant to the exercise of options under the Plan is 10,000,000. Eligible individuals include any employee or director of the Company and any consultant providing services to the Company. The expiration date and exercise price for each stock option grant are as established by the Board of Directors of the Company. No option may be issued under the Plan after February 1, 2027. On March 18, 2018, the Plan was amended to increase the maximum number of shares of stock that may be issued to 5,000,000. On July 10, 2018, the Plan was amended to increase the maximum number of shares of stock that may be issued to 5,500,000. In November of 2019, the Plan was further amended to increase the shares of stock that may be issued to 10,000,000.

 

During the six months ended October 31, 2021 and 2020, there were 500,000 and 0 common stock options granted. During the three months ended October 31,2021 and 2020, there were 0 and 0 common stock options granted.

 

Stock option activity during the six-month period ended October 31, 2021 is summarized as follows: 

                  
   Shares
Under
Option
   Price Per
Share
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
                
Outstanding - beginning of period   7,289,750    $0.00 - 1.50   $1.11   95 months
Granted   500,000    1.99    1.99   120 months
Exercised   (1,000,000)   0.01      
Canceled or expired             
Outstanding - end of period   6,789,750    $0.00 - 1.50   $1.31   82 months
                   
Exercisable - end of period   6,749,750        $1.05   76 months

 

 

 

 16 

 

 

Stock option activity during the period ended October 31, 2020, is summarized as follows: 

   Shares
Under
Option
   Price Per
Share
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
                
Outstanding - beginning of period   7,309,750    $0.00 - 1.50   $1.18   113 months
Granted             
Exercised             
Canceled or expired             
Outstanding - end of period   7,309,750    $0.00 - 1.50   $1.15   109 months
                   
Exercisable - end of period   6,469,750        $0.91   92 months

   

7. RELATED PARTY TRANSACTIONS

 

During the six months ended October 31, 2021 and 2020, the Company incurred consulting fees of $90,491 and $120,442 to four separate entities owned by four current shareholders. During the three-month period ended October 31, 2021 and 2020, the Company incurred $23,649 and $22,950 in consulting fees to three separate entities owned by three current shareholders. The total related party consulting fees unpaid balance due was $18,000 and $28,550 as of October 31, 2021 and April 30, 2021, respectively, and is included in accounts payable in the accompanying consolidated balance sheets.

 

The Company is in effect a sales representative of CBI. pursuant to the Exclusive Patent License Agreement between the Company and CBI. CBI and the Company are companies under the common control of E. Thomas Layton, the Company’s chairman and chief executive officer. There are no other transactions or contracts between CBI and the Company other than those discussed in this report. There was $3,936 and $1,670 due to CBI as of October 31, 2021 and April 30, 2021, respectively.

 

Two separate related parties are allowing the Company to rent vehicles for a monthly fee of $1,650 and $2,957. For the six months ended October 31, 2021, the Company paid a total of $9,900 and $17,742. For the three months ended October 31, 2021, the Company paid a total of $4,950 and $8,871. For the six months ended October 31, 2020, the Company paid a total of $8,250 and $19,942. For the three months ended October 31, 2020, the Company paid a total of $4,950 and $5,916.

 

8. INCOME TAXES

 

For the six months ended October 31, 2021 and 2020, the effective tax rate of 0% varies from the U.S. federal statutory rate primarily due to net losses and the valuation allowance associated with the net operating loss carryforwards. The Company continually reviews the realizability of its deferred tax assets, including an analysis of factors such as future taxable income, reversal of existing taxable temporary differences, and tax planning strategies. The Company continues to record a full valuation allowance against its net deferred tax assets. The Company assessed whether a valuation allowance should be established against its deferred tax assets based on consideration of all available evidence, using a “more likely than not” standard. In assessing the need for a valuation allowance, the Company considered both positive and negative evidence related to the likelihood of realization of deferred tax assets. In making such assessment, more weight was given to evidence that could be objectively verified, including recent cumulative losses. Future sources of taxable income were also considered in determining the amount of the recorded valuation allowance. Based on the Company’s review of this evidence at October 31, 2021, management determined that a full valuation allowance against all of the Company’s deferred tax assets at October 31, 2021 was appropriate.

 

 

 

 17 

 

 

The following table summarizes the difference between the actual tax provision and the amounts obtained by applying the statutory tax rates to the income or loss before income taxes for the period ending October 31, 2021 and 2020: 

               
    October 31,
2021
    October 31,
2020
 
Tax benefit calculated at statutory rate     21.00%       21.00%  
Expense not deductible     (0.03)       (0.02)  
Changes to valuation allowance     (20.97)       (20.98)  
Provision for income taxes     0%       0%  

 

9. CORONA VIRUS

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic has significantly impacted the economic conditions in the U.S., accelerating during the first half of March, as federal, state and local governments react to the public health crisis, creating significant uncertainties in the U.S. economy. In March 2020, we noticed a strong decline in orders from our customers, as businesses around the country began to cease their operations due to COVID-19. In an attempt to mitigate the ongoing impact of the pandemic on our cash flows certain actions were taken. The actions include targeted reductions in discretionary operating expenses such as advertising and payroll expenses, reducing capital expenditures, and reducing travel for business development purposes. As of October 31, 2020, we have noticed an increase in monthly orders as businesses have reopened, coupled with the spring/summer construction season. We have begun to increase our associated expenses including business travel and development.

 

The Paycheck Protection Program (“PPP”) provides loans from the U.S. Small Business Administration (“SBA”) to help businesses keep their workforce employed during the Coronavirus (COVID-19) crisis. SBA will forgive loans if all employees are kept on the payroll for eight weeks and the money is used for payroll, rent, mortgage interest, or utilities. On May 8, 2020, the Company received a PPP loan in the amount of $100,344. The loan was fully forgiven in November of 2020.

 

On February 11, 2021, WSC received $40,625 from the Paycheck Protection Program. The PPP Loan has a five-year term and bears interest at a rate of 1% per annum and does not require collateral. Monthly principal and interest payments are deferred for ten months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. WSC has not yet applied for forgiveness but believes it will be forgiven.

 

On February 14, 2021, ICS received $48,510 from the Paycheck Protection Program. The PPP Loan has a five-year term and bears interest at a rate of 1% per annum and does not require collateral. Monthly principal and interest payments are deferred for ten months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. ICS has not yet applied for forgiveness but believes it will be forgiven.

 

On March 16, 2021, SPE received $15,657 from the Paycheck Protection Program. The PPP Loan has a five-year term and bears interest at a rate of 1% per annum and does not require collateral. Monthly principal and interest payments are deferred for ten months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. SPE has not yet applied for forgiveness but believes it will be forgiven.

 

Continued impacts of the pandemic have had a material adverse impact on our revenues, earnings, liquidity and cash flows, and may require additional actions in response, including, but not limited to, employee layoffs, reduced production, or further expense reductions, all in an effort to mitigate such impacts. The extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including the duration of the spread of the outbreak within the U.S., and the related /impact on consumer confidence and spending, all of which are highly uncertain and cannot be predicted. This situation is rapidly changing and additional impacts to the business may arise that we are not aware of currently. While the disruption is currently expected to be temporary, there is uncertainty around the duration. The ultimate impact of the pandemic on the Company’s results of operations, financial position, liquidity, or capital resources cannot be reasonably estimated at this time.

 

 

 

 18 

 

 

11. SUBSEQUENT EVENTS

 

 

On November 22, 2021, the Company amended its stock option plan to increase the number of options available to 15,000,000.

 

On November 22, 2021, the Company granted 4,010,000 options to 13 people at an exercise price of $0.25 per option.

 

On December 1, 2021, the Company granted 800,000 options to two investors at an exercise price of $0.25 per option for the cancellation of indebtedness owed by the Company.

 

 

 

 

 

 

 

 19 

 

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with its unaudited interim condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited financial statements and notes thereto as of and for the fiscal year ended April 30, 2021.

 

FORWARD-LOOKING STATEMENTS

 

The discussion contained herein contains "forward-looking statements" that involve risk and uncertainties. These statements may be identified by the use of terminology such as "believes," "expects," "may," "should" or anticipates" or expressing this terminology negatively or similar expressions or by discussions of strategy. The cautionary statements made in this Form 10-Q should be read as being applicable to all related forward-looking statements wherever they appear in this Form 10-Q. The Company’s actual results could differ materially from those discussed in this report.

 

BUSINESS AND PLAN OF OPERATION

 

Lux Amber, Corp., based in Frisco, Texas, is an international specialty chemical company with many products that are friendly to the environment. The common description is “green chemicals.” The Company has degreed chemists on staff with years of successful experience in the specialty chemical industry. The term “specialty chemicals” is best defined by those chemicals whose formulas allow the chemical compounds to perform a specific function for a class of customers. The Company’s products have been used successfully in a diverse array of applications, including:

 

  · Chemicals to protect surfaces in asphalt handling equipment

 

  · Chemicals to control the reproduction of pests

 

  · Military Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) sites

 

  · Commercial nuclear power plants and nuclear-powered ships

 

  · Hazardous toxic industrial chemical and toxic industrial material clean-up

  

The Company’s corporate telephone number is 972-214-9764. The Company’s stock symbol is LXAM.

 

LAC has three (3) wholly owned subsidiaries (collectively with LAC, the “Company”): Worldwide Specialty Chemicals, Inc. (“WSC”), Industrial Chem Solutions, Inc. (“ICS”), and Safeway Pest Elimination, LLC, (“SPE”), which was formed July 16, 2018. LAC and its subsidiaries serve as both producers and distributors of environmentally safe, specialty chemicals. The Company formerly held a 49% interest in PCNM LLC, a Service-Disabled Veteran owned small business that sold the Company’s products to government agencies. PCNM was legally dissolved on July 31, 2020.

 

The Company’s products utilize all-natural and renewable resources, contain no dangerous chemicals or additives, and offer “green” solutions to its customers. ICS’ product line includes asphalt release agents, industrial cleaners, environmental remediation gels, odor control agents, and consumer friendly cleaners for a wide range of uses, including construction, environmental remediation, hazardous materials clean-up, nuclear decommissioning, industrial cleaning, and odor control. SPE’s products are designed for the elimination and control of pests.

 

LIQUIDITY AND CAPITAL RESOURCES

 

During the six-month period ended October 31, 2021, the primary sources of liquidity were cash flows from financing activities, and in particular, issuance of stock and promissory notes.

 

As of October 31, 2021, the Company had total assets of $3,407,314 consisting of current assets of $277,601, $178,556 in receivables, $85,528 in inventory, $13,517 in prepaid expenses and other current assets, and long-term assets of $2,309,953 in goodwill and other intangibles, $451,136 in fixed assets, $26,965 on other long-term assets, and $341,659 in right of use assets. As of April 30, 2021, the Company had total assets of $3,353,460, consisting of current assets of $112,982 in receivables, $137,211 in inventory, $7,960 in prepaid expenses and other current assets and long-term assets of $2,309,953 in goodwill and other intangibles, and $512,697 in fixed assets and $272,657 in right of use assets.

 

 

 

 20 

 

 

As of October 31, 2021, the Company had total liabilities totaling $2,820,283 including $2,088,675 in current payables and accrued expenses, $66,522 in related party payables, $240,627 notes payable, $104,752 in Paycheck protection program loans, and $319,707 in right of use liabilities. As of April 30, 2021, the Company had total liabilities totaling $2,468,547 including $1,756,156 in accounts payable and accrued expenses, $208,756 in related party payables, $127,624 in notes payable, and $271,259 in lease liabilities, and $104,752 in Paycheck protection program loans.

 

As October 31, 2021, the Company had an accumulated stockholders’ equity of $587,031 and $884,913 at April 30,2021. The increase is result of the items discussed below.

 

RESULTS OF OPERATIONS

  

Comparison of the three and six-month periods ended October 31, 2021 and October 31, 2020.

 

Revenues

 

For the three-month period ended October 31, 2021, the Company had revenues of $433,920, and $396,155 for the same period in 2020. The increase in sales is primarily the result of 1) expanded business with legacy customers to service additional Hot Mix Asphalt Plants under their ownership; 2) increase in sales price per unit; 3) addition of new customers.

 

For the six-month period ended October 31, 2021, the Company had revenues of $857,748, and $686,415 for the same period in 2020. The increase in sales is primarily the result of 1) expanded business with legacy customers to service additional Hot Mix Asphalt Plants under their ownership; 2) increase in sales price per unit; 3) addition of new customers.

 

Cost of Goods Sold decreased as a percentage of revenues due to a change in the mix of products sold during the period and increases in the gross selling prices on all the products offered by the company.

 

Operating Expenses

 

For the six-month period ended October 31, 2021, the Company’s operating expenses totaled $1,082,454 which included $272,639 in product delivery expenses, $719,302 in general and administrative expenses, $10,542 in selling expenses and $79,971 in depreciation of assets. For the six-month period ended October 31, 2020, the Company had operating expenses that totaled $1,439,745 which included $301,266 in product delivery expenses, $1,027,757 in general and administrative expenses, $35,755 in selling expenses and $74,967 in depreciation.

 

For the three-month period ended October 31, 2021, the Company’s operating expenses totaled $544,359 which included $119,424 in product delivery expenses, $383,144 in general and administrative expenses, $3,440 in selling expenses and $38,351 in depreciation of assets. For the three-month period ended October 31, 2020, the Company had operating expenses that totaled $771,460 which included $159,285 in product delivery expenses, $555,979 in general and administrative expenses, $18,513 in selling expenses and $37,683 in depreciation.

 

The decrease is primarily due to 1) Less travel cost due to more efficient use of mobile assets; 2) Shifting the cost burden of delivery to the customer; 3) Improved cost accounting processes; 4) Improved purchasing processes by sourcing raw materials from multiple vendors and buying in larger quantities.

 

GOING CONCERN

 

The accompanying consolidated financial statements are presented on a going concern basis. The Company's financial condition raises substantial doubt about the Company's ability to continue as a going concern. The Company has limited cash, its current liabilities exceed its current assets as of October 31, 2021 and has incurred reoccurring losses from operations during the six months ended October 31, 2021. The Company is relying on capital from investors to meet the majority of its operating expenses.

 

 

 

 21 

 

 

OFF-BALANCE SHEET ARRANGEMENTS

  

There are no off-balance sheet transactions, arrangements, obligations (including contingent obligations), or other relationships with unconsolidated entities or other persons that have, or may have, a material effect on financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources of the Company.

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

The Company’s management, with the participation of its President and Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934), as of the end of the period covered by this Quarterly Report on Form 10-Q.  Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, its disclosure controls and procedures are not effective.

 

INTERNAL CONTROL OVER FINANCIAL REPORTING

 

As indicated in the Company’s Form 10-K filed on September 30, 2021, the Company’s Principal Executive Officer and Principal Financial Officer concluded that its internal control over financial reporting was not effective during the 2021 fiscal year.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

During the period covered by this report, there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 

 

 

 

 

 

 

 

 

 

 22 

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the risks to the Company’s business from those described in its Annual Report on Form 10-K for the fiscal year ended April 30, 2021, as filed with the SEC on September 30, 2021.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

To assist the Company to obtain and preserve working capital to support its current operations the Company entered into the following transactions:

 

On July 13, 2021, the Company sold 200,000 common shares at $0.50 per share for a total cash amount of $100,000.

 

On July 23, 2021, the Company sold 100,000 common shares at $0.50 per share for a total cash amount of $50,000.

 

On July 23, 2021, the Company sold 100,000 common shares at $0.50 per share for an assigned note receivable.

 

On September 20, 2021, the Company issued 60,000 shares of at $0.33 per share for payment of $20,000 of outstanding payables.

 

On September 20, 2021, the Company issued 300,000 shares of at $0.33 per share for a total cash amount of $100,000.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

 

Exhibit No. Description
31.1 Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted in IXBRL and included in exhibit 101).

 

 23 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: December 17, 2021

 

  Lux Amber, Corp.
     
     
  By: /s/ E. Thomas Layton
    E. Thomas Layton, CEO and Director
     
  By: /s/ Paul O. Williams
    Paul O. Williams, CFO and Director

 

 

 

 

 

 

 24